ISRG
76
2
MTCH
42
5
SIG
49
6
EXR
60
3
GWW
71
4
HST
58
18
TXT
52
4
NWL
50
6
LEN
52
2
DE
56
10
EXPE
91
3
AMG
52
2
RHI
57
3
FDX
40
4
AFL
49
3
PPG
60
3
FE
52
3
SLG
66
2
KMX
64
6
DG
4
2
ISRG
76
2
MTCH
42
5
SIG
49
6
EXR
60
3
GWW
71
4
HST
58
18
TXT
52
4
NWL
50
6
LEN
52
2
DE
56
10
EXPE
91
3
AMG
52
2
RHI
57
3
FDX
40
4
AFL
49
3
PPG
60
3
FE
52
3
SLG
66
2
KMX
64
6
DG
4
2
Financhill
Back

Biomarin Pharmaceutical Vs. Bristol-Myers Squibb Industry Stock Comparison

Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Buy
58

BMY
Bristol-Myers Squibb

Last Price:
58.91
Seasonality Move:
2.73%
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Bristol-Myers Squibb (BMY) is a Buy

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $58.23. The Score for BMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $58.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 33.54 Sell
Chaikin Money Flow: 933432 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.12 - 69.52) Sell
Bollinger Bands (100): (68.19 - 87.29) Sell

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.45 Buy
Relative Strength Index (14 RSI): 60.65 Buy
Chaikin Money Flow: 3742798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.86 - 57.74) Buy
Bollinger Bands (100): (45 - 54.6) Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.96 Sell
20-day SMA: 65.96 Sell
50-day SMA: 68.96 Sell
200-day SMA: 81.18 Sell
8-day EMA: 63.79 Sell
20-day EMA: 65.7 Sell
50-day EMA: 69.97 Sell
200-day EMA: 79.54 Sell

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.91 Buy
20-day SMA: 55.92 Buy
50-day SMA: 53.36 Buy
200-day SMA: 48.46 Buy
8-day EMA: 57.57 Buy
20-day EMA: 56.26 Buy
50-day EMA: 53.76 Buy
200-day EMA: 50.72 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.49 per share, and an increase next year of $6.16 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):